Public affairs campaign in hostile ecosystem (environment) about the price question

Standing an American pharmaceutical company as a public health player, leader in cancer innovation

Opening the thought about the management of oncology patients care

Developing a positive environment to the market access for their product

Smoothen relations between the public authority and the pharmaceutical laboratories about the price question of the innovative products

Coordination of the round tables over 10 players (health professionals, patients, institutions)

Organization of conferences

A significant gain of awareness among the institutional players and public authorities

The first pharmaceutical laboratory to get out the negotiation on this category of products

White paper with the view of the stakeholders